PERGOLIDE MESYLATE (pergolide mesylate) by PharmaIN is clinical pharmacology pharmacodynamic information pergolide is a potent dopamine receptor agonist. First approved in 2002.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY Pharmacodynamic Information Pergolide is a potent dopamine receptor agonist. Pergolide is 10 to 1000 times more potent than bromocriptine on a milligram per milligram basis in various in vitro and in vivo test systems. Pergolide inhibits the secretion of prolactin in humans;…
Worked on PERGOLIDE MESYLATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Observational Study of Pergolide Mesylate and Cardiac Valvulopathy